Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
115.40    0.20 (0.17%)
Bid:
115.40
Ask:
115.80
Spread: 0.40 (0.347%)
Market Cap: £288.88m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Chief Financial Officer Appointment

27 Sep 2023 07:00

RNS Number : 7495N
Vanquis Banking Group PLC
27 September 2023
 

 

 

 

 

 

Vanquis Banking Group

Chief Financial Officer Appointment

27 September 2023

 

Vanquis Banking Group plc (the "Group") is pleased to announce the appointment of Dave Watts as Chief Financial Officer ("CFO"), subject to regulatory approval. Dave will join the Board and start as CFO in November 2023.

 

Dave Watts is a highly experienced CFO with extensive banking knowledge who has worked for HSBC for nearly 30 years. Dave has held a number of key CFO roles at HSBC, including CFO of HSBC UK Bank plc from 2017 to 2021, where he was instrumental in establishing HSBC's UK non-ring fenced bank. He is currently CFO for HSBC's European business. Prior to joining HSBC, Dave qualified as a Chartered Accountant with KPMG, and is a qualified treasurer.

 

Gareth Cronin, who has been acting as interim Chief Financial Officer since August, will continue in his role as Group Chief Risk Officer for the Group.

 

Ian McLaughlin, Chief Executive Officer, commented:

"Dave was the outstanding candidate in our CFO recruitment search process, and I look forward to working with him. His direct CFO and UK retail banking experience will be a great asset to the Board, the Group, and myself, as we move forward and grow the Group as a leading specialist bank. I would like to thank Gareth Cronin for acting as interim CFO and helping me immensely since I joined the Group as CEO in July."

 

Dave Watts commented:

"I am delighted to be joining Vanquis Banking Group as CFO. I look forward to working with Ian and the Board, as we continue to grow as a specialist banking group, helping customers who find it hard to access mainstream lenders, and deliver sustainable returns to our shareholders."

 

The following information is disclosed in accordance with LR 9.6.13:

In accordance with the Listing Rules, there are no other matters requiring disclosure under 9.6.13R of the Listing Rules of the Financial Conduct Authority in relation to the appointment of David Watts.

 

Enquiries:

Analysts and shareholders:

 

Miriam McKay, Interim Head of Investor Relations

07577 390666

miriam.mckay@vanquisbankinggroup.com

 

Media:

Richard King, Vanquis Banking Group

 

 

07919 866876

 

Nick Cosgrove/Simone Selzer, Brunswick

0207 4045959

vanquisbankinggroup@brunswickgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFSTATIRFIV
Date   Source Headline
8th Jul 20264:51 pmRNSHolding(s) in Company
6th Jul 202612:27 pmRNSNotice of Interim Results & Investor Presentations
3rd Jul 20264:00 pmRNSHolding(s) in Company
30th Jun 20264:30 pmRNSTotal Voting Rights
19th Jun 20263:05 pmRNSHolding(s) in Company
16th Jun 20264:00 pmRNSDirector/PDMR Shareholding
10th Jun 20269:53 amRNSHolding(s) in Company
29th May 20264:00 pmRNSTotal Voting Rights
29th May 20269:12 amRNSHolding(s) in Company
28th May 20261:37 pmRNSHolding(s) in Company
28th May 20268:39 amRNSHolding(s) in Company
22nd May 20269:00 amRNSTender Offer Final Results
21st May 20269:04 amRNSHolding(s) in Company
19th May 20263:15 pmRNSPublication of Offering Circular
15th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20262:58 pmRNSTender Offer - Maximum Acceptance
14th May 20269:18 amRNSTender Offer
6th May 202611:13 amRNSResult of AGM
6th May 20267:00 amRNS1st Quarter Results
30th Apr 20264:30 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSMotor Finance Redress Schemes Update
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20264:30 pmRNSTotal Voting Rights
18th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 20264:30 pmRNSNon-Executive Director Pension Transfer
4th Mar 20269:18 amRNSDirector/PDMR Shareholding
27th Feb 20264:34 pmRNSHolding(s) in Company
27th Feb 20264:30 pmRNSTotal Voting Rights
26th Feb 20267:00 amRNSPublication of Annual Report and AGM Notice
26th Feb 20267:00 amRNSResults for the year ended 31 December 2025
17th Feb 20264:30 pmRNSDirector/PDMR Shareholding
17th Feb 20263:54 pmRNSHolding(s) in Company
10th Feb 20263:33 pmRNSHolding(s) in Company
4th Feb 20264:32 pmRNSNotice of FY 2025 Results & Investor Presentations
30th Jan 20264:30 pmRNSTotal Voting Rights
30th Jan 20263:56 pmRNSHolding(s) in Company
23rd Jan 202612:40 pmRNSHolding(s) in Company
16th Jan 20262:55 pmRNSHolding(s) in Company
15th Jan 20264:30 pmRNSDirector/PDMR Shareholding
15th Jan 20263:02 pmRNSBlock listing Interim Review
8th Jan 20265:20 pmRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
16th Dec 20254:00 pmRNSDirector/PDMR Shareholding
9th Dec 20251:11 pmRNSHolding(s) in Company
8th Dec 20254:28 pmRNSHolding(s) in Company
5th Dec 20251:34 pmRNSHolding(s) in Company
28th Nov 20254:30 pmRNSTotal Voting Rights
24th Nov 20257:00 amRNSChange of Corporate Brokers

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.